Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 9 (HNRNPA1P9) is a **pseudogene**, meaning it is a non-functional genomic DNA sequence similar to the functional protein-coding gene HNRNPA1. Pseudogenes arise from duplication or retrotransposition of genes and typically harbor mutations, deletions, or truncations that prevent them from encoding functional proteins[1][5]. Unlike its parent gene HNRNPA1, which is a well-studied RNA-binding protein involved in RNA metabolism and splicing, there is no evidence that HNRNPA1P9 encodes a protein or is involved in canonical biological processes or disease mechanisms[1][5]. Some pseudogenes are known to be transcribed and participate in regulatory roles, but there is no current evidence that HNRNPA1P9 has such a function[1][5]. It is not recognized as a therapeutic target and is primarily catalogued as part of genomic annotation studies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 9 (HNRNPA1P9).